Targeting of the lysophosphatidic acid receptor 1 (LPA1) gene that has been implicated in promoting metastasis, via the specific inhibitor Debio-0719, was shown to induce dormancy at the secondary tumor site in a breast cancer model [97]. This evidence concerns the gene LPAR1 and breast cancer.